Anzeige
Mehr »
Freitag, 11.09.2026 - Börsentäglich über 12.000 News
Positiver Ausblick: "STRONG BUY" für NurExone Biologic!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10:46ABEC to expand global manufacturing network with new Wilson facility
DoEncoded secures $275m for Dravet syndrome gene therapy
DoBayer's Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion
DoHHS appoints permanent FDA CBER, CDER heads
DoSolstice Oncology secures $225m to drive porustobart's development for cancer
DoTwoStep Therapeutics secures $62.5m funding to advance TS-104
MiWhy China's rise needs to be taken with a pinch of salt
MiPharma's R&D, commercial approach shifts amid global policy evolution
MiMoonwalk banks $70m to progress siRNA therapy for obesity
Mi"Unparalleled opportunity": Sandoz embarks on ambitious biosimilar growth strategy
MiGilead launches research facility in US for new medicine development
MiFDA grants RMAT designation to RiboX's RXRG001 for xerostomia
MiQuoin in line for priority review voucher if rare paediatric drug approved
DiWhy the CNS boom owes its success to breakthroughs in neurological pathologies
DiQuoin in line for second priority review voucher if rare paediatric drug approved
DiUK on track to reverse years of pharma decline, ABPI report finds
DiLSTM opens $23m robotic AI lab for infection research
DiNovartis India acquires Pfizer brands for $132m
MoMosquitos capable of transmitting dengue found breeding in UK for first time
MoAptar Pharma to support Aceso's inhaled cystic fibrosis candidate's advance
MoEU pharma industry pushes for expansion of barcodes on medicines
MoAtomVie opens $160m radiopharmaceutical manufacturing facility in Ontario
MoFDA approves AstraZeneca's Etcamah combo for advanced breast cancer
04.09.Pineapples and green tea: FDA turns to public for new approaches to botanical drugs
04.09.Ionis nets Zanvastro US approval in first for Alexander disease